Explore LAMC2 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Secreted Protein/Potential Cytokines.
Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 2. The gamma 2 chain, formerly thought to be a truncated version of beta chain (B2t), is highly homologous to the gamma 1 chain; however, it lacks domain VI, and domains V, IV and III are shorter. It is expressed in several fetal tissues but differently from gamma 1, and is specifically localized to epithelial cells in skin, lung and kidney. The gamma 2 chain together with alpha 3 and beta 3 chains constitute laminin 5 (earlier known as kalinin), which is an integral part of the anchoring filaments that connect epithelial cells to the underlying basement membrane. The epithelium-specific expression of the gamma 2 chain implied its role as an epithelium attachment molecule, and mutations in this gene have been associated with junctional epidermolysis bullosa, a skin disease characterized by blisters due to disruption of the epidermal-dermal junction. Two transcript variants resulting from alternative splicing of the 3' terminal exon, and encoding different isoforms of gamma 2 chain, have been described. The two variants are differentially expressed in embryonic tissues, however, the biological significance of the two forms is not known. Transcript variants utilizing alternative polyA_signal have also been noted in literature. [provided by RefSeq, Aug 2011]
| Target ID |
GM-T75613
|
| Target Name |
LAMC2
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
3918
|
| Gene ID |
101089571 (Felis catus), 16782 (Mus musculus), 192362 (Rattus norvegicus), 3918 (Homo sapiens) 442939 (Canis lupus familiaris), 511043 (Bos taurus), 715212 (Macaca mulatta), 791245 (Equus caballus)
|
| Target Alternative Names |
B2T,BM600,CSF,Cell-scattering factor 140 kDa subunit (CSF 140 kDa subunit),EBR2,EBR2A,Epiligrin subunit gamma,JEB3A,JEB3B,Kalinin subunit gamma,Kalinin/nicein/epiligrin 100 kDa subunit,LAMB2T,LAMC2,LAMNB2,Ladsin 140 kDa subunit,Lamc2,Laminin B2t chain,Laminin subunit gamma-2,Laminin-5 subunit gamma,Large adhesive scatter factor 140 kDa subunit,Nicein subunit gamma
|
| Uniprot Accession |
Q61092,Q13753,Q8HZI9
|
| Protein Sub-location |
Secreted Protein/Potential Cytokines
|
| Category |
Therapeutics Target
|
| Disease |
cancer
|
| Disease from KEGG |
PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Toxoplasmosis, Amoebiasis, Human papillomavirus infection, Pathways in cancer, Small cell lung cancer
|
| Gene Ensembl |
ENSMUSG00000026479, ENSG00000058085, ENSCAFG00845004476, ENSBTAG00000000793, ENSMMUG00000001479, ENSECAG00000021903
|
| Target Classification |
Tumor-associated antigen (TAA)
|
Pre-made viral vector of LAMC2 cDNA Clones/ORF Plasmid
LAMC2 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo3918 | Pre-made Human LAMC2/B2T/CSF siRNA oligo Duplex | 3918 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo192362 | Pre-made Rat Lamc2 siRNA oligo Duplex | 192362 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo16782 | Pre-made Mouse Lamc2 siRNA oligo Duplex | 16782 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo715212 | Pre-made Cynomolgus/Rhesus macaque LAMC2 siRNA oligo Duplex | 715212 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101089571 | Pre-made Cat/Feline LAMC2 siRNA oligo Duplex | 101089571 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo442939 | Pre-made Dog/Canine LAMC2 siRNA oligo Duplex | 442939 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo511043 | Pre-made Bovines/Cattle LAMC2 siRNA oligo Duplex | 511043 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo791245 | Pre-made Equine/Horse LAMC2 siRNA oligo Duplex | 791245 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
LAMC2 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T75613-Ab | Human | Anti-Human LAMC2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T75613-Ab | Rat | Anti-Rat LAMC2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T75613-Ab | Mouse | Anti-Mouse LAMC2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T75613-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque LAMC2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T75613-Ab | Cat/Feline | Anti-Cat/Feline LAMC2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T75613-Ab | Dog/Canine | Anti-Dog/Canine LAMC2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T75613-Ab | Bovines/Cattle | Anti-Bovines/Cattle LAMC2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T75613-Ab | Equine/Horse | Anti-Equine/Horse LAMC2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
LAMC2 recombinant protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T75613-Ag | Human | Human LAMC2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-rg-T75613-Ag | Rat | Rat LAMC2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-mg-T75613-Ag | Mouse | Mouse LAMC2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-cynog-T75613-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque LAMC2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-felg-T75613-Ag | Cat/Feline | Cat/Feline LAMC2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-cang-T75613-Ag | Dog/Canine | Dog/Canine LAMC2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-bovg-T75613-Ag | Bovines/Cattle | Bovines/Cattle LAMC2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-equg-T75613-Ag | Equine/Horse | Equine/Horse LAMC2 recombinant protein | Mammalian cell | Detail |